WallStreetZenWallStreetZen

NASDAQ: SXTP
60 Degrees Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
60 Degrees Pharmaceuticals earnings were -$8.3M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest SXTP earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$1.8M, down 8.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SXTP reported annual earnings of -$8.4M, with 114.8% growth. The next SXTP earnings date is Nov 13, 2025.

SXTP earnings history

Current Revenue
$850.4k
Current Earnings
-$8.3M
Current Profit Margin
-976%

SXTP Return on Equity

Current Company
-199.8%
Current Industry
-10%
Current Market
30.7%
SXTP's Return on Equity (-199.8%)... subscribe to Premium to read more.
High Return on Equity Performance

SXTP undefined

Current Company
-142.2%
Current Industry
-0.2%
SXTP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SXTP announces earnings.

SXTP undefined

Current Company
-313.42%
Current Industry
6.4%

SXTP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SXTP-$7.74M-$8.30MN/A-$4.26
KTTA-$12.81M-$13.46MN/A-$7.55
TTNP-$2.81M-$2.81MN/A-$2.95
XBIO-$3.08M-$3.08MN/A-$2.00
MLEC-$5.72M-$8.28MN/A-$2.10
View Top Biotech Stocks

SXTP earnings dates

Next earnings date
Nov 13, 2025

60 Degrees Pharmaceuticals Earnings Reports & History FAQ

What were 60 Degrees Pharmaceuticals's earnings last quarter?

On SXTP's earnings call on Invalid Date, 60 Degrees Pharmaceuticals (NASDAQ: SXTP) reported Q2 2025 earnings per share (EPS) of -$1.25, up 94.08% year over year. Total SXTP earnings for the quarter were -$1.84 million. In the same quarter last year, 60 Degrees Pharmaceuticals's earnings per share (EPS) was -$21.12.

If you're new to stock investing, here's how to buy 60 Degrees Pharmaceuticals stock.

When does 60 Degrees Pharmaceuticals report earnings?

The next SXTP earnings date is Invalid Date. Add SXTP to your watchlist to be reminded of 60 Degrees Pharmaceuticals's next earnings date.

Is 60 Degrees Pharmaceuticals profitable or losing money?

As of the last 60 Degrees Pharmaceuticals earnings report, 60 Degrees Pharmaceuticals is currently losing money. 60 Degrees Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$7.82 million, a 397.34% increase year over year.

What was SXTP's earnings growth in the past year?

As of 60 Degrees Pharmaceuticals's earnings date in Invalid Date, 60 Degrees Pharmaceuticals's earnings has grown year over year. SXTP earnings in the past year totalled -$8.30 million.

What are 60 Degrees Pharmaceuticals's earnings expectations?

The current EPS estimate for 60 Degrees Pharmaceuticals's earnings report in Invalid Date is -$0.08.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.